Home›Stock Screener›Acutaas Chemicals›Financial Statements

Acutaas Chemicals Financial Statements

11 Years of Data
2026 - 2016

Acutaas Chemicals financial statements. In FY2026, Acutaas Chemicals (ACUTAAS) reported revenue ₹442 Cr, net profit ₹123 Cr and EPS ₹15.29, with a net profit margin of 27.8% and ROE of 7.2%. Full financial statements from FY2016 to FY2026 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. See ACUTAAS P/B ratio to compare market price against book value per share.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 27.83% 2026 data
EBITDA Margin 40.95% 2026 data
Operating Margin 40.00% 2026 data
Return on Assets 6.20% 2026 data
Return on Equity 7.19% 2026 data

Balance Sheet Ratios

Equity Ratio 86.24% 2026 data
Asset Turnover 0.22 2026 data

ACUTAAS Revenue, Net Profit & EBITDA — Year-on-Year Growth

ACUTAAS YoY (Sept 2025 vs Sept 2026) — revenue +39.9%, net profit +70.8%, EBITDA +72.4%, expenses +23.7%. Explore ACUTAAS fundamental worth to estimate fundamental worth using multiple valuation models.

Revenue Growth
+39.9%
Year-over-Year
Net Profit Growth
+70.8%
Year-over-Year
EBITDA Growth
+72.4%
Year-over-Year
Expense Growth
+23.7%
Year-over-Year
Assets Growth
+28.1%
Year-over-Year
Equity Growth
+29.6%
Year-over-Year
Operating Cash Flow Growth
+147.5%
Year-over-Year
Investing Cash Flow Growth
-18.8%
Year-over-Year
Financing Cash Flow Growth
-98.5%
Year-over-Year

ACUTAAS Income Statement — Revenue, EBITDA & Net Profit

Acutaas Chemicals revenue ₹442 Cr, EBITDA ₹181 Cr, net profit ₹123 Cr, EPS ₹15.29 (2026) — net profit margin 27.8%. For live price, earnings ratios and company overview, see Acutaas Chemicals share price screener.

Periods ₹ Crores
Particulars Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Jun 2020 Dec 2020
Revenue 442 444 332 316 314 223 398 255 226 178 277 174 186 155 170 148 144 132 155 123 93 114 143 92 65 92
Expenses 261 249 217 211 224 156 243 198 182 147 206 179 146 120 140 119 118 108 122 95 70 91 111 69 52 70
EBITDA 181 195 115 105 91 67 155 57 44 31 70 -5 41 35 30 29 26 24 34 28 23 23 31 23 14 22
Operating Profit Margin % 40.00% 42.00% 34.00% 31.00% 28.00% 25.00% 38.00% 20.00% 19.00% 17.00% 25.00% -4.00% 22.00% 22.00% 16.00% 19.00% 18.00% 18.00% 20.00% 22.00% 25.00% 20.00% 21.00% 24.00% 20.00% 24.00%
Depreciation 13 10 10 8 7 8 10 7 5 6 6 4 3 4 4 3 3 3 3 2 1 2 2 1 1 1
Interest 1 1 1 1 1 1 1 1 2 4 1 1 1 1 3 0 1 0 1 3 1 3 0 1 1 2
Profit Before Tax 167 184 104 96 83 58 145 50 37 20 63 -10 37 31 24 26 22 20 30 23 21 18 29 20 11 19
Tax 44 50 29 24 20 14 38 13 12 5 18 7 10 9 6 7 1 6 7 5 5 4 9 5 3 5
Net Profit 123 134 75 72 63 44 106 38 26 15 46 -17 27 22 18 19 21 15 22 18 15 14 20 15 9 15
Earnings Per Share (₹) 15.29 16.09 9.07 8.82 7.80 5.41 13.19 9.38 6.85 3.67 11.35 -4.67 7.47 4.57 4.83 5.50 6.22 4.08 6.28 5.11 4.89 4.36 5.69 4.83 8.49 4.59

ACUTAAS Balance Sheet — Assets, Liabilities & Shareholders' Equity

ACUTAAS total assets ₹1,984 Cr, total equity ₹1,711 Cr, total liabilities ₹ Cr (2026) — ROE 7.2%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019
ASSETS
Total Assets 1,984 1,549 1,096 767 659 413 232 213
Current Assets
Fixed Assets 745 570 427 259 205 186 85 79
Capital Work in Progress 332 130 125 30 3 0 12 2
Investments 0 0 0 2 2 1 2 2
Other Assets 907 848 543 477 450 225 133 131
LIABILITIES
Total Liabilities
Current Liabilities 42 27 128 10 7 80 26 25
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 1,711 1,320 683 594 522 167 112 82
Share Capital 41 41 37 36 36 32 11 11
Reserves & Surplus 1,613 1,269 637 558 486 135 101 72

ACUTAAS Cash Flow Statement — Operating, Investing & Financing

Acutaas Chemicals operating cash flow ₹292 Cr, investing ₹-266 Cr, financing ₹4 Cr, net cash flow ₹30 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016
Operating Activities 292 118 125 66 -12 28 27 15 9 29 10
Investing Activities -266 -224 -365 -33 -121 -101 -24 -21 -25 -19 -14
Financing Activities 4 261 239 -12 140 72 0 6 15 -7 4
Net Cash Flow 30 156 -1 20 8 -1 3 0 -2 3 0